go back

Maine rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,380,384 · 10th–90th $1,288,250–$1,380,3840%50%10th$1,380,384Professionalmedian $562,341 · 10th–90th $562,341–$676,0830%50%90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,288,249.55 / $1,380,384.26 / $1,380,384.26
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.03 / $0.03
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
Harvard Pilgrim
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
Martin's Point
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $588,843.66
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$60,255.96 / $60,255.96 / $60,255.96